Persistent CXCR4 expression after preoperative chemoradiotherapy predicts early recurrence and poor prognosis in esophageal cancer

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 47

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

332

HTML

2708

Figures (1-4)

250

Tables (1-2)

209

Sum=3499

Dec 21, 2006 (publication date) through Nov 4, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Esophageal Cancer

World J Gastroenterol. Dec 21, 2006; 12(47): 7585-7590
Published online Dec 21, 2006. doi: 10.3748/wjg.v12.i47.7585

Full Size Figure Download Figure

Figure 3 Overall survival in ESCC patients with no residual tumor or null CXCR4 expression and those with positive CXCR4 expression.

Citation: Koishi K, Yoshikawa R, Tsujimura T, Hashimoto-Tamaoki T, Kojima S, Yanagi H, Yamamura T, Fujiwara Y. Persistent CXCR4 expression after preoperative chemoradiotherapy predicts early recurrence and poor prognosis in esophageal cancer. World J Gastroenterol 2006; 12(47): 7585-7590
URL: https://www.wjgnet.com/1007-9327/full/v12/i47/7585.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i47.7585